The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Mycobacterium tuberculosis CDC1551 Induces a More Vigorous Host Response In Vivo and In Vitro, But Is Not More Virulent Than Other Clinical Isolates
Open accessAbstract
Mycobacterium tuberculosis CDC1551, a clinical isolate reported to be hypervirulent and to grow faster than other isolates, was compared with two other clinical isolates (HN60 and HN878) and two laboratory strains (H37Rv and Erdman). The initial (1–14 days) growth of CDC1551, HN60, HN878, and H37Rv was similar in the lungs of aerosol-infected mice, but growth of Erdman was slower. Thereafter, the growth rate of CDC1551 decreased relative to the other strains which continued to grow at comparable rates up to day 21. In the lungs of CDC1551-infected mice, small well-organized granulomas with high levels of TNF-α, IL-6, IL-10, IL-12, and IFN-γ mRNA were apparent sooner than in lungs of mice infected with the other strains. CDC1551-infected mice survived significantly longer. These findings were confirmed in vitro. The growth rates of H37Rv and CDC1551 in human monocytes were the same, but higher levels of TNF-α, IL-10, IL-6, and IL-12 were induced in monocytes after infection with CDC1551 or by exposure of monocytes to lipid fractions from CDC1551. CD14 expression on the surface of the monocytes was up-regulated to a greater extent by exposure to the lipids of CDC1551. Thus, CDC1551 is not more virulent than other M. tuberculosis isolates in terms of growth in vivo and in vitro, but it induces a more rapid and robust host response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Self-citationAn essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., & Nickbarg, E. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1387 · Cited by 1,144
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationInterleukin-12 and its role in the generation of TH1 cells
Trinchieri, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90230-i · Cited by 845
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 821
Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1797 · Cited by 720
Molloy, A., Laochumroonvorapong, P., & Kaplan, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1499 · Cited by 508
Self-citationWysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250307 · Cited by 467
An Outbreak Involving Extensive Transmission of a Virulent Strain of Mycobacterium tuberculosis
Valway, S. E., Sanchez, M. P. C., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., & Onorato, I. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381001 · Cited by 386
Denis, M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90014-3 · Cited by 333
Barnes, P. F., Chatterjee, D., Abrams, J. S., Lu, S., Wang, E., Yamamura, M., Brennan, P. J., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.541 · Cited by 294
Frucht, D. M., & Holland, S. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.411 · Cited by 172
Laochumroonvorapong, P., Wang, J., Liu, C. C., Ye, W., Moreira, A. L., Elkon, K. B., Freedman, V. H., & Kaplan, G. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.127-132.1997 · Cited by 138
Self-citationNorth, R. J., & Izzo, A. A. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.6.1723 · Cited by 137
Silver, R. F., Li, Q., & Ellner, J. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1190-1199.1998 · Cited by 131
Giambartolomei, G. H., Dennis, V. A., Lasater, B. L., & Philipp, M. T. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.140-147.1999 · Cited by 114
Cytokines and the Koch phenomenon
Rook, G. A. W., & Attiyah, R. A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90019-o · Cited by 98
Bernardo, J., Billingslea, A. M., Blumenthal, R. L., Seetoo, K. F., Simons, E. R., & Fenton, M. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.28-35.1998 · Cited by 91
Laochumroonvorapong, P., Paul, S., Elkon, K. B., & Kaplan, G. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.452-459.1996 · Cited by 83
Self-citationConti, P., Reale, M., Nicolai, M., Barbacane, R. C., Placido, F. C., Iantorno, R., & Tenaglia, R. L. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01517205 · Cited by 35
Aerosol Infection of Mice with Mycobacteria Using a Nose-Only Exposure Device
Tsenova, L., Moreira, A. L., Party, E., Freedman, V. H., & Kaplan, G. (1997) · Applied Biosafety · doi:10.1177/109135059700200307 · Cited by 17
Self-citationJacobs, W. R., Brennan, P. J., Curlin, G. T., Ginsberg, A. M., Adams, M. J., Fleischmann, R., Fraser, C. M., Venter, J. C., Shinnick, T. M., Bishai, W. R., et al. (1996) · Science · doi:10.1126/science.274.5284.17 · Cited by 9
Cited by
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Self-citationGagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains
Fleischmann, R. D., Alland, D., Eisen, J. A., Carpenter, L., White, O., Peterson, J., DeBoy, R., Dodson, R., Gwinn, M., Haft, D., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5479-5490.2002 · Cited by 672
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Self-citation
Metadata
- Authors
- Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06-01
- Volume
- 162
- Issue
- 11
- Pages
- 6740-6746
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1945178855
- Cited by
- 306
- References
- 26
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.